Acasti Pharma Inc EV/EBIT
¿Qué es el EV/EBIT de Acasti Pharma Inc?
El EV/EBIT de Acasti Pharma Inc es N/A
¿Cuál es la definición de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT de compañías en Sector Health Care en NASDAQ en comparadas con Acasti Pharma Inc
¿Qué hace Acasti Pharma Inc?
acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.
Empresas con ev/ebit similar a Acasti Pharma Inc
- Halo Collective tiene EV/EBIT de N/A
- Nkarta tiene EV/EBIT de N/A
- Manugraph India tiene EV/EBIT de N/A
- Guild Esports Plc tiene EV/EBIT de N/A
- Clarity Gold tiene EV/EBIT de N/A
- Radha Madhav tiene EV/EBIT de N/A
- Acasti Pharma Inc tiene EV/EBIT de N/A
- Akers Biosciences Inc tiene EV/EBIT de N/A
- Agios Pharmaceuticals Inc tiene EV/EBIT de N/A
- Generation Bio Co tiene EV/EBIT de N/A
- Purple Biotech tiene EV/EBIT de N/A
- Panbela Therapeutics tiene EV/EBIT de N/A
- Continental Materials tiene EV/EBIT de N/A